The Nanowear Wearable Covid-19 Observational and Analysis Trend
Status: Recruiting
Location: See all (2) locations...
Intervention Type: Device
Study Type: Observational
SUMMARY
The NanoCOAT study is a multi-center, prospective, non-randomized, feasibility, observational, non-significant risk study. The NanoCOAT study will enroll a minimum of 10 and a maximum of 100 subjects in a potential for a multi-site in order to collect data and analyze physiological and biometric trends due to Covid-19.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Subject has provided informed consent
• Male or female over the age of 18 years
• The patient is currently hospitalized with a primary diagnosis of Covid-19
Locations
United States
New Jersey
Hackensack University Medical Center
NOT_YET_RECRUITING
Hackensack
New York
Maimonides Medical Center
RECRUITING
Brooklyn
Time Frame
Start Date: 2020-09-15
Estimated Completion Date: 2023-12-31
Participants
Target number of participants: 100
Related Therapeutic Areas
Sponsors
Leads: Nanowear Inc.